How to Read and Trade AI Powered Stock Charts
Enter Stock Symbol to View AI powered Stock Chart
StockChartsAI.com
All Chart Prices as of Previous Day CloseBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
12/07/2023 16:00:00 EST
Certara Inc (CERT)
Industry: Health Information Services
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 30 trading days, CERT has been trading in a range between $14.97 and $12.12 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
CERT is trading between resistance at $16.67 about 4% to the upside and support at $14.38 -11% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $19.16, about a 19% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
Certara Inc (CERT) entered a Green zone 17 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 3.750, which is a Buy. The current analyst target price is $18.57, which gives it a potential upside of 15.34 % from the recent price of 16.10. The stock is trading 55.03% (potential upside) below its 52 week high of $24.96 and 36.33 % (potential downside) above its 52 week low of $11.81 - based on the recent price.
Company Summary
Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.
News
| Certara introduces Simcyp™ Biopharmaceutics software to increase efficiency of novel and generic drug formulation & development Certara's Simcyp™ Biopharmaceutics software helps biopharmaceutic, formulation & CMC scientists formulate complex new and generic drugs faster and cheaper. Source: GlobeNewsWire Tue, 21 Nov 2023 16:30:00 -0500 Sentiment: Neutral |
| Certara Inc. (CERT) Q3 2023 Earnings Call Transcript Certara Inc. (NASDAQ:CERT ) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ET Company Participants David Deuchler - Investor Relations William Feehery - Chief Executive Officer John Gallagher - Chief Financial Officer Conference Call Participants Jeff Garro - Stephens Inc David Windley - Jefferies Mike Ryskin - Bank of America Max Smock - William Blair Joe Vruwink - Baird Vikram Purohit - Morgan Stanley Operator Good day, and thank you for standing by. Welcome to the Certara Third Quarter 2023 Earnings Conference Call. Source: Seeking Alpha Wed, 08 Nov 2023 22:41:08 -0500 Sentiment: Neutral |
| Certara, Inc. (CERT) Q3 Earnings Meet Estimates Certara, Inc. (CERT) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.10 per share a year ago. Source: Zacks Investment Research Wed, 08 Nov 2023 20:17:04 -0500 Sentiment: Positive |
| Certara Reports Third Quarter 2023 Financial Results PRINCETON, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results for the third quarter of fiscal year 2023. Source: GlobeNewsWire Wed, 08 Nov 2023 16:10:00 -0500 Sentiment: Neutral |
| Circling Back On Certara Certara, Inc. provides biosimulation software and services to the biotech and biopharma industry. The company is enjoying sales growth from its software division in the mid-teen but service growth is lagging. Analysts have mixed opinions on Certara's prospects even as the company is expanding its AI capabilities. An updated analysis is provided in the paragraphs below. Source: Seeking Alpha Tue, 17 Oct 2023 14:36:21 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 24.96 52 Week Low: 11.81 Beta: 1.573 50 Day MA: 13.8526 200 Day MA: 18.1003 Earnings / Revenue Trends Qtr Earnings Growth YOY: -0.141 Qtr Revenue Growth YOY: 0.01 Forward PE: 33.0033 Trailing PE: 0